Drug Trial Radar · NCT01400425
Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline
Last checked: Nov 19, 2026Latest source record: Mar 29, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
239
Actual
Start
Jul 2011
Primary completion
Jul 2012
Study completion Jul 2012
Sponsor
- Lead sponsor
- Avid RadiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jul 22, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is designed to evaluate whether a florbetapir F 18 PET scan can impact clinical thinking when physicians are determining the likely cause of a subject's cognitive impairment.
Conditions
- Progressive Cognitive Decline
Interventions
florbetapir F 18Drug
IV injection, 370 megabecquerel (MBq) (10 millicurie \[mCi\]), single dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects Who Undergo a Hypothetical Change in Clinical Diagnosis and Physician Management Plan After Obtaining a Negative Florbetapir F 18 PET Scan.Time frame: 6 weeks
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Phoenix, Arizona
Research Site
Sun City, Arizona
Research Site
San Francisco, California
Research Site
Boulder, Colorado
Research Site
Boynton Beach, Florida
Research Site
Clearwater, Florida
Research Site
Fort Myers, Florida
Research Site
West Palm Beach, Florida
Research Site
Shreveport, Louisiana
Research Site
Quincy, Massachusetts
Research Site
Las Vegas, Nevada
Research Site
New York, New York
Research Site
Patchogue, New York
Research Site
Durham, North Carolina
Research Site
Greensboro, North Carolina
Research Site
Providence, Rhode Island
Research Site
Providence, Rhode Island
Research Site
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.